Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vimseltinib
vimseltinib
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
Fierce Pharma
Sun, 02/16/25 - 07:33 pm
Ono Pharmaceutical
FDA
vimseltinib
tenosynovial giant cell tumors
Deciphera's tumor-tackling oral med achieves 40% response rate, teeing up 2024 submission
Fierce Biotech
Mon, 10/30/23 - 08:10 pm
Deciphera Pharma
clinical trials
tenosynovial giant cell tumors
vimseltinib